Pericapsular Nerve Group Block for Positional Pain and Postoperative Analgesia in Hip Fractures
NCT ID: NCT05079087
Last Updated: 2021-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2021-04-01
2022-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Evaluate the effectiveness of the pericapsulare blockade of the femoral nerve, the accessory obturator nerve and the obturator nerve in patients with pertrochanteric fractures of the femur, during the pre-operative period for patient positioning manoeuvres (sitting position for performing spinal anaesthesia, mobilisation on the operating bed, etc.);
* Evaluate the consumption of opioids or hypnotics in the perioperative period, which are more responsible for the incidence of delirium in the elderly patient;
* Evaluate the duration and quality of postoperative analgesia and well-being.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patient mobilisation for the administration of spinal anaesthesia as well as post-operative care require effective perioperative pain management. In current practice, this is achieved by the administration of systemic analgosedative treatment. Ideally, the use of opioids or ketamine should be minimized since their side effects are major morbidity factors. Peripheral nerve blocked can be an efficient to foster pre- and postoperative analgesia and therefore minimize the need for opioids.
Currently, the psoas compartment block is considered to be the most reliable peripheral nerve block for analgesia in pertrochanteric femoral fractures, although it is technically rather difficult to perform and could be associated with serious side effects. Alternative approaches, such as the femoral nerve block, the Iata band block or the 3-in-1 block often do not possess a sufficient reliable analgesic effect in this kind of injury. Thus so far, peripheral nerve blocks are not routinely applied in clinical practice in most cases.
The anterior capsule of the hip joint is the most innervated area of the entire joint.
The nerves involved are:
* The obturatorial nerve
* The accessory nerve of the obturator
* The femoral nerve Adequate anaesthesia for pertrochanteric femoral facture requires the blockage of all three nerves. In 2018, Gíron-Arango et al., developed a novel ultrasound guided approach for the blockade these nerves, the Pericapsular nerve group (PENG) block. The investigators consider this peripheral nerve block a potentially beneficial technique to implement in the treatment of per trochanteric femur fracture patients.
Patients with a pertochanteric femoral fracture admitted to the orthopaedics department for surgical treatment will be asked whether they are willing to participate to the study. After transfer of the patient to Anaesthesiology, before performing any additional analgesic measures, the NRS at rest and on the movement of the affected limb (extension of 20°) will be evaluated. The 4AT test for the assessment of delirium will be performed to obtain a baseline value. The participants will be randomly assigned to two groups. Due to the fact that these patients need swift treatment for their injury, our randomisation is based on alternating assignments to the two groups based on the time patients sign their informed consent for study participation. The investigators have no indication that this randomisation procedure could lead to a bias. The first group will consist of patients that undergo PENG block administering a mixture of Ropivacaine 0.5% + Dexamethasone 4 mg in a volume of 20 ml before performing the spinal anaesthesia. There is one report indicating that a 1:1 mixture of ropivacaine 0.75% with 4mg/mL dexamethasone could pose a risk due to crystal formation. However, in our clinical practice, where the investigators mix 0.5% in a 1:20 ratio, thus producing an injection containing 30-times less dexamethasone, the investigators did never experience problems with crystallisation. This is extensively backed by literature. In any case, the patients will be informed about the off-label nature of perineural dexamethasone during the anaesthesiologic visit.
The PENG-block will be administered under ultrasound (US) guidance with a low frequency curvilinear probe. The probe will be placed parallel to the inguinal crease at the level of the anterior superior iliac spine. Scanning will be done with gradual caudal movement of the probe. After the anterior inferior iliac spine (AIIS) is visible, the probe will be turned slightly medial until the hyperechoic continuous shadow of the superior pubic ramus is visible. The Psoas muscle with its prominent tendon will be identified just above the pubic ramus. The target is the plane between the 2 structures. While aligning the pubic ramus in the center of the image and targeting the pubic ramus just medial to the AIIS, a 22 Go 10 cm needle will be introduced and 20 ml of anesthetic solution administered. The participants are informed about the specifics of the PENG blocks and the risks (which are minor) during the anesthesiologic visit.
Patients in the second group will undergo sedation and analgesic treatment with Ketamine and Midazolam titrated to the best Verbal Rating Score without respiratory and cardiovascular depressant effect. 30 minutes after the PENG block or the drug treatment, immediately before mobilization for the spinal anaesthesia, the assessment of NRS at rest and on movement of the affected limb (extension of 20°) will be repeated.
Spinal anaesthesia will be performed using 2.5mL isobaric bupivacaine 0.5% applying state of the art care.
After surgical intervention in postoperative care, patients do not receive fix systemic analgesia as post-operative pain should be covered by the PENG block. However, in the post-operative are they will receive Paracetamol, Metamizole and Buprenorphine if necessary. Once they are transferred to the orthopaedics department, patients analgesia will be managed according to the orthopaedics department standardized protocols. In any case, post-operative opiate consumption will be recorded. To assess post-operative pain management performance in the two groups, the NRS at rest and on movement of the affected limb (extension of 20°) will be evaluated 18 hours after the PENG block. In order to avoid too much discomfort for the patients and to not induce unnecessary inflammation in the surgical area, the investigators refrain of doing too many measurements. The investigators expect that the the 18 hours measurement together with the evaluation of post-operative opiate use will give us a clear image of post-operative pain control. Also, 18 hours after, the 4AT test will be performed to quantify symptoms of delirium. Furthermore, the occurrence of PONV and patient satisfaction on a VAS-Scale will be evaluated.
The primary endpoint is the NRS variations during movement of the affected limp (extension of 20°) before and 30 minutes as well as 18 hours after performing the PENG block or analgosedation. Secondary endpoints are occurrence of delirium quantified by the 4AT test, if and who much and which rescue opiate was used, occurrence of PONV and patient satisfaction expressed on a VAS-Scale.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PENG BLOCK arm
The first arm will consist of patients that undergo PENG block administering a mixture of Ropivacaine 0.5% + Dexamethasone 4 mg in a volume of 20 ml before performing the spinal anaesthesia.
Pericapsular nerve group blockade
The PENG-block will be administered under ultrasound (US) guidance with a low frequency curvilinear probe. The probe will be placed parallel to the inguinal crease at the level of the anterior superior iliac spine. Scanning will be done with gradual caudal movement of the probe. After the anterior inferior iliac spine (AIIS) is visible, the probe will be turned slightly medial until the hyperechoic continuous shadow of the superior pubic ramus is visible. The Psoas muscle with its prominent tendon will be identified just above the pubic ramus. The target is the plane between the 2 structures. While aligning the pubic ramus in the center of the image and targeting the pubic ramus just medial to the AIIS, a 22 Go 10 cm needle will be introduced and 20 ml of anesthetic solution administered.
Ketamine- Midazolam arm
The second arm consist in Patients that will undergo sedation and analgesic treatment with Ketamine and Midazolam titrated to the best Verbal Rating Score without respiratory and cardiovascular depressant effect.
Midazolam Ketamine arm
Patients in the second group will undergo sedation and analgesic treatment with Ketamine and Midazolam titrated to the best Verbal Rating Score without respiratory and cardiovascular depressant effect.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pericapsular nerve group blockade
The PENG-block will be administered under ultrasound (US) guidance with a low frequency curvilinear probe. The probe will be placed parallel to the inguinal crease at the level of the anterior superior iliac spine. Scanning will be done with gradual caudal movement of the probe. After the anterior inferior iliac spine (AIIS) is visible, the probe will be turned slightly medial until the hyperechoic continuous shadow of the superior pubic ramus is visible. The Psoas muscle with its prominent tendon will be identified just above the pubic ramus. The target is the plane between the 2 structures. While aligning the pubic ramus in the center of the image and targeting the pubic ramus just medial to the AIIS, a 22 Go 10 cm needle will be introduced and 20 ml of anesthetic solution administered.
Midazolam Ketamine arm
Patients in the second group will undergo sedation and analgesic treatment with Ketamine and Midazolam titrated to the best Verbal Rating Score without respiratory and cardiovascular depressant effect.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Lack of informed consent
* Pathological skin alterations
* Intertrigo at the puncture site level.
* Allergy to any of the drugs
* Coagulopathy
* Sepsis
* Use of direct oral anticoagulatns (DOACs)
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Sanitaria dell'Alto Adige
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paolo Seraglio
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda sanitaria Allo Adige ospedale di Merano
Meran, Bolzano, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01
Identifier Type: -
Identifier Source: org_study_id